StreetInsider.com News Articles

Form D Lifeward Ltd.

Wed, 08 Jul 2026 14:52:00 -0400

si-local-file:///var/storage/secattach/20260708/26747171.html

Form D Lifeward Ltd.

Wed, 08 Jul 2026 14:52:00 -0400

si-local-file:///var/storage/secattach/20260708/26747171.html

Form 8-K Lifeward Ltd. For: Jun 30

Tue, 07 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260707/26742165.html

Form 8-K Lifeward Ltd. For: Jun 30

Tue, 07 Jul 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260707/26742165.html

Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones

Tue, 07 Jul 2026 16:15:33 -0400

Lifeward Ltd. (Nasdaq: LFWD) closed an initial $5.6 million in senior secured convertible notes and accompanying warrants on July 6, 2026, as part of a financing agreement with a group of institutional and accredited investors.

The deal includes a commitment from investors to provide an additional $5.6 million upon the achievement of one of two defined milestones: a 150% increase in ReWalk unit sales over the trailing twelve-month period, or Lifeward's ordinary shares trading at or above $13.80 per share for ten consecutive trading days.

The financing was structured through a securities purchase agreement connected to a broader capital framework established with

Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones

Tue, 07 Jul 2026 16:15:33 -0400

The financing was structured through a securities purchase agreement connected to a broader capital framework established with

Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones

Tue, 07 Jul 2026 16:15:33 -0400

The financing was structured through a securities purchase agreement connected to a broader capital framework established with

Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones

Tue, 07 Jul 2026 16:15:33 -0400

The financing was structured through a securities purchase agreement connected to a broader capital framework established with

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Tue, 07 Jul 2026 16:15:00 -0400

Initial $5.6 million provides immediate capital to accelerate commercialization of Lifeward's restorative healthcare platform; additional $5.6 million available upon achievement of defined commercial and financial milestones

HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced that it has entered into a securities purchase agreement with a group of institutional and accredited investors participating in the strategic financing framework established earlier this year with Oramed

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Tue, 07 Jul 2026 16:15:00 -0400

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Tue, 07 Jul 2026 16:15:00 -0400

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Tue, 07 Jul 2026 16:15:00 -0400

Oramed to join Russell indexes amid $270M balance sheet

Thu, 25 Jun 2026 11:35:21 -0400

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP, TASE: ORMP) issued a letter to shareholders on June 25, 2026, outlining key financial and strategic developments, including its anticipated addition to the Russell 2000 and Russell 3000 indexes.

Oramed is expected to join both indexes effective at the U.S. market open on June 29, 2026, as part of FTSE Russell's 2026 annual reconstitution. The company reported total cash and assets of approximately $270 million as of March 31, 2026 (unaudited), after paying a $10.5 million dividend in January 2026.